Navigation Links
Development of prosthetic hands stagnated for 20 years
Date:6/12/2012

The development of body-powered prosthetic hands has stagnated for over twenty years. That is the main conclusion of a study by researchers from TU Delft and the University of Groningen into this type of prosthesis, which is published in the American Journal of Rehabilitation Research and Development.

High operating force

The study, which was carried out by researchers from TU Delft and the University of Groningen, measured the force required to operate a number of contemporary body-powered prosthetic hands. The researchers compared the results to earlier measurements from 1987 and came up with remarkable results: today's prosthetic hands perform equally or less well than those from 1987. The grip strength of the hands is insufficient and a very high operating force is required. Another remarkable result: a prosthetic hand developed in 1945 performed better in the test than the newer prosthetic hands.

User overload

TU Delft researcher Gerwin Smit: "The study offers a possible explanation why over half of all people with a body-powered prosthetic hand do not use it or even wear it. Besides this, some prosthetic arm users tend to suffer overload problems over time. These problems may well be a result of the excessive operating force required." This is currently being researched further in Groningen and Delft.

Electrical alternative?

Worldwide over 30% of prosthesis users wear a body-powered prosthesis. A body-powered prosthesis is operated by pulling a cable (a little like the brake cable on your bike). This cable is attached to a harness worn on the opposite shoulder. Subtle movements between the arm wearing the prosthesis and the opposite shoulder pull the cable taut and open the prosthesis. Another popular prosthesis is the electric prosthesis. This is worn by about 40% of prosthesis users worldwide. Then there are also cosmetic prostheses.

The big question that the researchers raised as a result of this study was why there is hardly any investment in body-powered prostheses. Gerwin Smit: "With current technology it must be possible to easily improve prostheses, resulting in enormous progress for those who have to use them. In recent decades, millions have been invested in electric prostheses. The difference in price between the types of prosthesis may have influenced this, as the retail price of an electric prosthesis is around 10 to 100 time higher than a body-powered prosthesis. This makes it more attractive from a commercial point of view to invest in electric prostheses. Yet despite the investments, electric prostheses are slower and heavier than body-powered prostheses."

New developments

In order to solve the problems of prosthesis users, TU Delft is working on making improvements to body-powered prosthetic hands. The ultimate aim is to develop a lightweight prosthetic hand with a lower operating force and a higher grip strength.


'/>"/>

Contact: Ilona van den Brink
i.vandenbrink@tudelft.nl
31-152-784-259
Delft University of Technology
Source:Eurekalert

Related biology news :

1. New Tool Helps Drug Developers Optimize Their Research and Target Development for Better Results and a Stronger Competitive Edge
2. Navigating the Patent Minefield of Embryonic Stem Cell Product Development; Free Kindle Fire Tablet and Research Database with Purchase
3. Mice with big brains provide insight into brain regeneration and developmental disorders
4. Understanding the RNAi Reagents Market Overlap with Drug Discovery and Therapeutic Development is Critical for Pharmaceutical Leaders
5. UC Riverside receives grant for global health and development research
6. Navigating the IP Minefield of Human Embryonic Stem Cell Development
7. Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinsons drug development tools
8. New genes contributing to autism and related neurodevelopmental disorders uncovered
9. Gut microbiota transplantation may prevent development of diabetes and fatty liver disease
10. Europe meets to discuss progress in energy research and development
11. Promising developments in early diagnosis and treatment of mesothelioma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/9/2017)... -- The biomass boiler market report by Transparency Market ... globally in terms of revenue (US$ Mn) based on ... biomass boilers has been segmented on the basis of ... market based on feedstock type, has been segmented into ... crops, urban residues, and others. On the basis of ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... 22, 2017  UBM and the Massachusetts Medical ... extended partnership and the third annual Massachusetts Medtech Week. ... 21 st Annual MassMEDIC Conference held in ... 3-4, 2017. MassMEDIC will feature ... President and CEO, Scott Whitaker , at ...
(Date:3/22/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... ), a clinical-stage pharmaceutical company focused on the ... that Dr. Miriam Kidron , Oramed,s Chief ... Insulin for Diabetes Treatment: Bypassing the Roadblock," at ... Therapeutics (OPT) Boston Conference in Cambridge, Massachusetts ...
(Date:3/22/2017)... ALBANY, New York , March 22, 2017 /PRNewswire/ ... market is largely fragmented, states a research report by ... Sanofi S.A., Pfizer Inc., Amgen Inc., and AbbVie Inc., ... market in 2015. The prominent players in this market ... to expand their product portfolio, which is likely to ...
(Date:3/22/2017)... , March 22, 2017 /PRNewswire/ - FACIT announced ... "Company" or "Propellon"), a start-up created by FACIT ... therapeutics. FACIT,s investment, combined with non-dilutive capital, achieves ... The seed funding enables Propellon to accelerate the ... Company for financing and/or entering a strategic partnership ...
Breaking Biology Technology: